Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
-Medical News
 Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory

 

 

 
FDA Approves Generic AIDS Drugs
 

The U.S. Food and Drug Administration (FDA) approved generic versions of the anti-
retroviral drug azidothymidine (AZT), used to inhibit the spread of the AIDS virus in
HIV patients. This approval became possible upon the recent expiration of a long-
standing patent. The pharmaceutical company GlaxoSmithKline had been the exclusive
commercial manufacturer of AZT.

The recent FDA licensing of generic AZT drugs made by Ranbaxy Laboratories of
Guragon, India, Aurobindo Pharma of Hyderabad, India and Roxane Laboratories of
Columbus, OH allows less expensive HIV treatment alternatives to be released into the
market. "These approvals will now allow those infected with HIV more access to these
life-saving drugs within our country," said Mike Leavitt, secretary of the Department of
Health and Human Services.

Source: The New York Times, September 20, 2005

 

This section of our Web site is sponsored by: